Kindred Healthcare (KND)
Kindred Healthcare R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these KND related companies
KND News
Kindred Healthcare Announces Voting Results for the 2012 Annual Meeting of Shareholders
May 17, 5:05PM Business Wire
May 17, 5:05PM Business Wire
Kindred Healthcare Appoints Benjamin A. Breier President and Chief Operating Officer
May 17, 5:00PM Business Wire
May 17, 5:00PM Business Wire
Top 4 Small-Cap Stocks In The Long-Term Care Facilities Industry With The Highest Cash
May 14, 2:21AM Benzinga
May 14, 2:21AM Benzinga
Listen to $KND Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3clz
about 28 days ago by earningscast
about 28 days ago by earningscast
@missyaubaby Since you mostly trade breakout here are two that I love a lot right now $GLW, $KND. And one that I am watching closely $MWW.
about 28 days ago by Dtheone
about 28 days ago by Dtheone
2012 Economic Outlook - Report Highlights Kindred Healthcare, Inc. and C.R. Bard, Inc.
Apr 26, 9:00AM Marketwire
Apr 26, 9:00AM Marketwire
Kindred (KND), Other Long-Term Care Providers Surge as CMS Proposes to Cut Reimbursement Rates
Apr 25, 12:03PM Street Insider
Apr 25, 12:03PM Street Insider
Avondale Partners Upgrades Kindred Healthcare (KND) to Market Outperform
Apr 25, 11:10AM Street Insider
Apr 25, 11:10AM Street Insider
$KND is Now a PinBall Play with a Gap up over both the 2 EMA and the T-Line with T-Line cross http://stks.co/3RA0
about 40 days ago by GoofyGolfa
about 40 days ago by GoofyGolfa
$KND Left/Right Combo after ( ! ) ( ! ) ( ! ) setting up as a Pinball play with the T-Line cross http://stks.co/3OyP
about 42 days ago by GoofyGolfa
about 42 days ago by GoofyGolfa
Top 4 NYSE Stocks In The Long-Term Care Facilities Industry With The Highest ROA
Apr 04, 4:06AM Benzinga
Apr 04, 4:06AM Benzinga
$KND filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3CKy
about 57 days ago by MarketBrief
about 57 days ago by MarketBrief
News related to $KND, currently -2.6% since open: 'Kindred Healthcare shares sink after 4Q loss' http://stks.co/2YFH
about 96 days ago by TradeBot
about 96 days ago by TradeBot
Listen to $KND Q4 2011 earnings call - live at 11:00 AM, ondemand after - http://stks.co/2Y9P
about 96 days ago by earningscast
about 96 days ago by earningscast
$KND Upside Blowoff - 15 Minute Down Reversal - Red bar after 4 green bars
about 99 days ago by TradeIdeasQuant
about 99 days ago by TradeIdeasQuant
$KND Upside Blowoff - 15 Minute Down Reversal - Red bar after 5 green bars
about 162 days ago by TradeIdeasQuant
about 162 days ago by TradeIdeasQuant
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| KND | 8.58 | -0.38 | -4.24% | 466.91M |
| KMX | 28.09 | -1.37 | -4.65% | 6.675B |
| KMR | 71.79 | -1.37 | -1.87% | 7.322B |
| KMPR | 28.95 | -0.57 | -1.93% | 1.776B |
| KMP | 78.97 | -0.97 | -1.21% | 18.61B |
| KHI | 9.99 | +0.02 | +0.20% | |
| KH | 19.67 | +0.02 | +0.10% | 448.81M |
| KGN | 3.40 | +0.10 | +3.03% | 249.25M |
| KGJI | 2.53 | -0.04 | -1.56% | 136.49M |
| KGC | 8.145 | +0.03 | +0.31% | 9.238B |
